Category: Uncategorized
Panorama Study For Patients With Diabetic Retinopathy
Clinical Trial for Patients with NPDR Dear Respected Colleague, We are pleased to inform you that CFR is participating as a recruiting study site in the Regeneron Pharmaceuticals, Inc. PANORAMA study: a phase 3 study of the efficacy and safety of intravitreal (IVT) aflibercept in patients with moderately severe to severe NPDR. Approximately 360 patients […]